Can Molecular Profiling Truly Revolutionize How We Approach Early and Late-Stage Colorectal Cancer? – APGCS
Asia-Pacific Gastroenterology Cancer Summit shared on LinkedIn:
“Can molecular profiling truly revolutionize how we approach early and late-stage colorectal cancer?
This critical question takes center stage at APGCS 2025 during our panel discussion: ‘Molecular MDT in mCRC: Challenging Cases in Early and Late-Stage CRC’
1 August, 2025 | 11:50 – 12:30 SGT
We are pleased to feature Dr. Iain Tan, Senior Consultant Medical Oncologist at National Cancer Centre Singapore.
Dr. Tan leads the colorectal cancer service at NCCS and is also a clinician-scientist at A*STAR Genome Institute of Singapore (A*STAR GIS). His dual role allows him to bridge cutting-edge molecular research with clinical practice, focusing on early detection and personalized strategies for colorectal cancer.
Expect case-driven discussion, actionable insights, and interdisciplinary perspectives as part of this dynamic Molecular Tumor Board panel.
Secure your spot.”
More posts featuring Colorectal Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023